TP53-mutant CHIP defines a pro-inflammatory phenotype and predicts adverse outcomes after CAR T-cell therapy
Leukemia
The paper
Giulia Rappa, Frank Ziemann, Kieron White, Marion S. Subklewe
Show 16 more authors
Linus Kruk, Samar Shamas, Amelie Muth, Kayleen Shi, Cristina Zucchinetti, Savanna Süß, Maja Rothenberg‐Thurley, Alessandra Holzem, Tobias Tix, Agnese Petrera, Bianka Ksienzyk, Charlotte Bentenrieder, Katharina S. S. Götze, Fabian Müller, Veit Bücklein, Kai Rejeski,LMU Klinikum · German Cancer Research Center
Leukemia · 24 Aug 2026
